Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia

J. P. Lewis, Frederick J Meyers, L. Tanaka

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission-induction regimens for ANLL.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalBritish Journal of Haematology
Volume61
Issue number2
StatePublished - 1985

Fingerprint

Daunorubicin
Intravenous Infusions
Acute Myeloid Leukemia
Anthracyclines
Remission Induction
Therapeutics
Incidence

ASJC Scopus subject areas

  • Hematology

Cite this

Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia. / Lewis, J. P.; Meyers, Frederick J; Tanaka, L.

In: British Journal of Haematology, Vol. 61, No. 2, 1985, p. 261-265.

Research output: Contribution to journalArticle

@article{e8a2d49e5b134d35992917ab673a789f,
title = "Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia",
abstract = "Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission-induction regimens for ANLL.",
author = "Lewis, {J. P.} and Meyers, {Frederick J} and L. Tanaka",
year = "1985",
language = "English (US)",
volume = "61",
pages = "261--265",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia

AU - Lewis, J. P.

AU - Meyers, Frederick J

AU - Tanaka, L.

PY - 1985

Y1 - 1985

N2 - Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission-induction regimens for ANLL.

AB - Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission-induction regimens for ANLL.

UR - http://www.scopus.com/inward/record.url?scp=0021947221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021947221&partnerID=8YFLogxK

M3 - Article

C2 - 4041369

AN - SCOPUS:0021947221

VL - 61

SP - 261

EP - 265

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -